Bausch Health Companies Inc. (BHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1B 2B 3B Q3 '16: 2.5B Q4 '16: 2.4B Q1 '17: 2.1B Q2 '17: 2.2B Q3 '17: 2.2B Q4 '17: 2.2B Q1 '18: 2B Q2 '18: 2.1B Q3 '18: 2.1B Q4 '18: 2.1B Q1 '19: 2B Q2 '19: 2.2B Q3 '19: 2.2B Q4 '19: 2.2B Q1 '20: 2B Q2 '20: 1.7B Q3 '20: 2.1B Q4 '20: 2.2B Q1 '21: 2B Q2 '21: 2.1B Q3 '21: 2.1B Q4 '21: 2.2B Q1 '22: 1.9B Q2 '22: 2B Q3 '22: 2B Q4 '22: 2.2B Q1 '23: 1.9B Q2 '23: 2.2B Q3 '23: 2.2B Q4 '23: 2.4B Q1 '24: 2.2B Q2 '24: 2.4B Q3 '24: 2.5B Q4 '24: 2.6B Q1 '25: 2.3B Q2 '25: 2.5B Q3 '25: 2.7B Q4 '25: 2.8B Q1 '26: 2.5B Q2 '26: 2.9B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-2.4B -1.6B -800M 0 800M 1.6B 2.4B Q2 '16: 81M Q3 '16: -863M Q4 '16: 150M Q1 '17: 211M Q2 '17: 175M Q3 '17: 38M Q4 '17: -322M Q1 '18: -2.3B Q2 '18: -245M Q3 '18: 117M Q4 '18: 25M Q1 '19: 287M Q2 '19: 257M Q3 '19: 329M Q4 '19: -1.1B Q1 '20: 248M Q2 '20: -27M Q3 '20: 460M Q4 '20: -5M Q1 '21: -221M Q2 '21: -270M Q3 '21: 574M Q4 '21: 367M Q1 '22: 285M Q2 '22: 161M Q3 '22: 244M Q1 '23: 175M Q2 '23: 412M Q3 '23: 14M Q4 '23: 362M Q1 '24: 281M Q2 '24: 389M Q3 '24: 318M Q4 '24: 558M Q1 '25: 276M Q2 '25: 444M Q3 '25: 619M Q4 '25: 474M Q1 '26: -950M Q2 '26: 740M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-2.7B -1.8B -900M 0 900M 1.8B 2.7B Q3 '16: -1.2B Q4 '16: -512M Q1 '17: 629M Q2 '17: -37M Q3 '17: 1.3B Q4 '17: 512M Q1 '18: -2.6B Q2 '18: -872M Q3 '18: -351M Q4 '18: -342M Q1 '19: -48M Q2 '19: -170M Q3 '19: -48M Q4 '19: -1.5B Q1 '20: -152M Q2 '20: -326M Q3 '20: 71M Q4 '20: -153M Q1 '21: -610M Q2 '21: -595M Q3 '21: 188M Q4 '21: 69M Q1 '22: -69M Q2 '22: -145M Q3 '22: 399M Q4 '22: -410M Q1 '23: -201M Q2 '23: 26M Q3 '23: -378M Q4 '23: -39M Q1 '24: -64M Q2 '24: 10M Q3 '24: -85M Q4 '24: 93M Q1 '25: -58M Q2 '25: 148M Q3 '25: 179M Q4 '25: -112M Q1 '26: -1.4B Q2 '26: 258M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '16: 569M Q4 '16: 512M Q1 '17: 954M Q2 '17: 268M Q3 '17: 490M Q4 '17: 578M Q1 '18: 438M Q2 '18: 222M Q3 '18: 522M Q4 '18: 319M Q1 '19: 413M Q2 '19: 339M Q3 '19: 515M Q4 '19: 234M Q1 '20: 261M Q2 '20: 200M Q3 '20: 256M Q4 '20: 394M Q1 '21: 443M Q2 '21: 395M Q3 '21: 564M Q4 '21: 24M Q1 '22: -63M Q2 '22: 123M Q3 '22: -1.3B Q4 '22: 475M Q1 '23: 154M Q2 '23: 206M Q3 '23: 282M Q4 '23: 390M Q1 '24: 211M Q2 '24: 380M Q3 '24: 405M Q4 '24: 601M Q1 '25: 211M Q2 '25: 289M Q3 '25: 405M Q4 '25: 495M Q1 '26: 230M Q2 '26: 670M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-1.5B -1B -500M 0 500M 1B 1.5B Q3 '16: 516M Q4 '16: 458M Q1 '17: 916M Q2 '17: 231M Q3 '17: 447M Q4 '17: 525M Q1 '18: 405M Q2 '18: 192M Q3 '18: 490M Q4 '18: 257M Q1 '19: 366M Q2 '19: 277M Q3 '19: 432M Q4 '19: 156M Q1 '20: 189M Q2 '20: 131M Q3 '20: 175M Q4 '20: 314M Q1 '21: 377M Q2 '21: 333M Q3 '21: 501M Q4 '21: -54M Q1 '22: -109M Q2 '22: 71M Q3 '22: -1.3B Q4 '22: 409M Q1 '23: 107M Q2 '23: 178M Q3 '23: 240M Q4 '23: 292M Q1 '24: 129M Q2 '24: 302M Q3 '24: 334M Q4 '24: 495M Q1 '25: 96M Q2 '25: 190M Q3 '25: 314M Q4 '25: 403M Q1 '26: 121M Q2 '26: 593M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '13: 305.8M Q2 '13: 314.4M Q3 '13: 333.6M Q1 '14: 334.9M Q2 '14: 341.3M Q3 '14: 341.3M Q1 '15: 343.4M Q2 '15: 344.4M Q3 '15: 351M Q1 '16: 344.9M Q2 '16: 345M Q3 '16: 349.5M Q1 '17: 350.5M Q2 '17: 350.1M Q3 '17: 352.3M Q1 '18: 350.7M Q2 '18: 351.3M Q3 '18: 351.5M Q1 '19: 351.3M Q3 '19: 352.4M Q1 '20: 353.4M Q2 '20: 355.3M Q3 '20: 357.8M Q1 '21: 356.8M Q2 '21: 359.1M Q3 '21: 364M Q1 '22: 360.8M Q2 '22: 362.2M Q3 '22: 363.4M Q1 '23: 363.3M Q2 '23: 367.1M Q3 '23: 365.4M Q1 '24: 366.8M Q2 '24: 370.2M Q3 '24: 368.4M Q1 '25: 369.6M Q2 '25: 373.1M Q3 '25: 375.5M Q1 '26: 372.8M Q2 '26: 378.1M Q2 '14 Q1 '16 Q3 '17 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q3 '16: -6.57 Q4 '16: -6.92 Q1 '17: -4.05 Q2 '17: -3.28 Q3 '17: 3.90 Q4 '17: 6.82 Q1 '18: -2.33 Q2 '18: -4.71 Q3 '18: -9.40 Q4 '18: -11.83 Q1 '19: -4.62 Q2 '19: -2.62 Q3 '19: -1.76 Q4 '19: -5.09 Q1 '20: -5.37 Q2 '20: -5.80 Q3 '20: -5.46 Q4 '20: -1.58 Q1 '21: -2.86 Q2 '21: -3.60 Q3 '21: -3.28 Q4 '21: -2.64 Q1 '22: -1.12 Q2 '22: 0.14 Q3 '22: 0.72 Q4 '22: -0.62 Q1 '23: -0.98 Q2 '23: -0.51 Q3 '23: -2.64 Q4 '23: -1.61 Q1 '24: -1.23 Q2 '24: -1.27 Q3 '24: -0.47 Q4 '24: -0.13 Q1 '25: -0.12 Q2 '25: 0.25 Q3 '25: 0.96 Q4 '25: 0.42 Q1 '26: -3.24 Q2 '26: -2.96 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.